Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 12/20 | 0.42 |
| ▸ | ACHE | P22303 | 4/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL6395405 | 0.82 | MEN1 (0.48) | MEN1KMT2ALMNABCHEACHE | |
| SCHEMBL4080875 | 0.79 | MEN1 (0.52) | MEN1KMT2ALMNABCHEACHE | |
| SCHEMBL4088094 | 0.68 | NOX1 (0.42) | MEN1KMT2ALMNABCHEACHE | |
| SCHEMBL4343072 | 0.68 | NOX1 (0.39) | MEN1KMT2ALMNABCHEACHE | |
| SCHEMBL6262674 | 0.66 | MEN1 (0.52) | MEN1KMT2ALMNABCHEACHE | |
| SCHEMBL9818558 | 0.64 | LMNA (0.50) | MEN1KMT2ALMNABCHEACHE | |
| SCHEMBL18607005 | 0.64 | KEAP1 (0.44) | PTGER1PTGER4PTGER3PTGER2 | |
| SCHEMBL13182856 | 0.64 | KDM4E (0.53) | ALDH1A1NPSR1PTGER1PTGER4PTGER3 | |
| SCHEMBL9105213 | 0.64 | BCHE (0.36) | BCHEACHEHRH2HTR2ASLC6A4 | |
| SCHEMBL4088074 | 0.64 | BCHE (0.38) | MEN1KMT2ALMNABCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576201-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2009-08-18 | — | — | US | disclosed |
| US-20080167465-A1 | Electrochromic compound | FITZMAURICE DONALD | 2008-07-10 | — | — | US | disclosed |
| US-7253940-B2 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND (IE) | 2007-08-07 | — | — | US | disclosed |
| US-20050128562-A1 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | disclosed |
| US-20050128561-A1 | Electrochromic compound | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | disclosed |
| US-6870657-B1 | Electrochromic device | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-03-22 | — | — | US | disclosed |
| EP-1500969-A1 | Compound and its use in electrochromic devices | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167465-A1 | Electrochromic compound | KCNH2, PRDM9, H1-10 | MEN1 3335/4885KMT2A 161/4885LMNA 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.